Company Filing History:
Years Active: 2010
Title: Don M Coltart: Innovator in Glycoconjugate Research
Introduction
Don M Coltart is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of glycoconjugates and glycoamino acids. His innovative work focuses on the synthesis and application of these compounds in cancer treatment.
Latest Patents
Coltart holds a patent for "Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof." This invention provides novel glycosides and glycoconjugates, as well as glycoamino acids, along with methods for their synthesis. Additionally, the patent includes clustered glycopeptides and methods for their synthesis. Importantly, it outlines methods for treating cancer, particularly in preventing recurrence and inducing antibodies in subjects through the administration of effective amounts of the inventive glycopeptides.
Career Highlights
Coltart is affiliated with the Sloan-Kettering Institute for Cancer Research, where he conducts his research. His work has been instrumental in advancing the understanding of glycoconjugates and their potential therapeutic applications.
Collaborations
Coltart has collaborated with notable colleagues, including Samuel J Danishefsky and Stacy J Keding. These partnerships have further enriched his research and contributed to the development of innovative solutions in cancer treatment.
Conclusion
Don M Coltart's contributions to glycoconjugate research highlight his role as a key innovator in the field. His patent and ongoing work at the Sloan-Kettering Institute for Cancer Research demonstrate his commitment to advancing cancer treatment methodologies.